【摘要】：2015年12月,美國、歐盟和日本共批準23個新藥,包括新分子實體、新有效成分、新生物制品、新增適應證及新劑型藥物。對全球首次獲得批準的新分子實體、新有效成分、新生物制品進行分析,重點介紹這些藥物的臨床研究結果和研發(fā)歷史進程。
[Abstract]:In December 2015, the United States, the European Union and Japan approved 23 new drugs, including new molecular entities, new active ingredients, new biological products, new indications and new dosage forms. The new molecular entities, new active components and new biological products approved for the first time in the world were analyzed, and the clinical research results and the research and development history of these drugs were introduced in detail.
【分類號】：R95
，

本文編號：2456966